Furthermore, human equilibrium nucleoside transporter protein 1 (hENT1) was able to effectively reverse gemcitabine-induced resistance by inhibiting glycolysis and regulating HIF-1α in pancreatic cancer, further demonstrating that the regulation of glucose transporter’s potential role in PDAC drug resistance (126). Here, HIF1A is linked to familial pancreatic carcinoma.